Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORBIT-1: Ciprofloxacin for Inhalation in Non-CF Bronchiectasis
NCT00889967Phase 2Completed
- Sponsor
- Paradigm Biopharmaceuticals
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ciprofloxacin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Paradigm Biopharmaceuticals. Started Feb 2010; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT00889967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889967.